Hologic is the latest partner to join the NEST Governance Committee which convenes a diverse group of leaders from across the medical device ecosystem—including regulatory agencies, industry ...

Medical equipment maker Hologic rejected an up to $16.7 billion non-binding offer from private equity firms TPG and Blackstone , the Financial Times reported on Tuesday, citing people familiar ...

Hologic declined a $16 billion buyout bid from TPG and Blackstone as it faces falling shares and tariff-related headwinds, leaving room for deal talks to potentially resume.

Shares of Hologic advanced after the Financial Times reported the company received and rejected a nonbinding buyout offer from TPG and Blackstone. The medical technology company's stock was up 14% ...

The Hall of Fame Open has awarded its first WTA main draw wildcards to former world No. 5 Genie Bouchard and American Christina McHale, while rising star Anna Frey has accepted a qualifying wildcard. ...

Shares of Hologic Inc. HOLX shed 2.92% to $54.82 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.61% to 5,844.61 and ...

Hologic, Inc. (NASDAQ: HOLX) Q2 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Mike Watts - Corporate VP, IR Steve MacMillan - Chairman, President & CEO Essex Mitchell ...

MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Hologic Inc. (HOLX) on Thursday reported a loss of $17.4 million in its fiscal second quarter. The Marlborough, Massachusetts-based company ...

Shares of Hologic Inc. HOLX advanced 1.45% to $59.31 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to 5,456.90 ...

Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday.

With Hologic's limited service timeline and uncertain parts availability, many medical facilities may find themselves unprepared for the long-term viability of their Fluoroscan InSight FD Mini C-Arms.